Urea

CHEMBL985 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
60.1 g/mol
LogP
-1.4
Phase
4

Urea is an endogenous metabolic waste product of protein catabolism that, in pharmaceutical concentrations, acts as a keratolytic and humectant when applied topically, disrupting hydrogen bonds in keratin to soften and hydrate hyperkeratotic skin. At higher concentrations, it is used to treat nail disorders and as a topical agent for ichthyosis, psoriasis, and xerosis. It also has pharmaceutical applications as an osmotic agent and as a diagnostic marker in breath tests for Helicobacter pylori.

Masse moléculaire

60,0560 g/mol

LogP

-1,40

TPSA

69,10 Ų

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Mécanisme d'action

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mécanisme

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

NC(N)=O

InChI

InChI=1S/CH4N2O/c2-1(3)4/h(H4,2,3,4)

Molecular Formula

CH4N2O

HBD / HBA

2 / 1

Liaisons Rotatives

0

Atomes Lourds

4

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

Urea is an endogenous metabolic waste product of protein catabolism that, in pharmaceutical concentrations, acts as a keratolytic and humectant when applied topically, disrupting hydrogen bonds in keratin to soften and hydrate hyperkeratotic skin. At higher concentrations, it is used to treat nail disorders and as a topical agent for ichthyosis, psoriasis, and xerosis. It also has pharmaceutical applications as an osmotic agent and as a diagnostic marker in breath tests for Helicobacter pylori.

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Yes, Urea is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL985. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 1176. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.